Furthermore, mTOR, a downstream target of ERα, p53, and AMPK, has been reported to play an important role in resistance of LBC to ET [32,33,34,35,36,37]. The gene discussed is MTOR; the disease is CDH1-related diffuse gastric and lobular breast cancer syndrome.